期刊文献+

重组分泌型肿瘤坏死因子相关凋亡诱导配体腺病毒对PC-3细胞荷瘤鼠瘤体的生长抑制

Suppression effect of secreting-trail adenovirus on the prostate cancer PC-3 cells in the tumor bearing mice
下载PDF
导出
摘要 目的探讨表达分泌型TRAIL基因的腺病毒载体对人前列腺癌PC-3细胞荷瘤鼠的生长抑制作用。方法 DAPI染色检测各组PC-3细胞凋亡的情况。Transwell实验检测Ad-s TRAIL对PC-3细胞体外侵袭能力的影响。成功建立PC-3荷瘤鼠模型,经Ad-s TRAIL和Ad-Lac Z分别处理后检测瘤体的生长抑制率。免疫组化实验检测裸鼠移植瘤内TRAIL表达的变化。TUNEL检测瘤体内肿瘤细胞的凋亡。结果 DAPI染色显示Ad-s TRAIL组肿瘤细胞凋亡水平明显高于Control组和Ad-Lac Z组。Transwell实验显示Ad-s TRAIL组穿入下室面的细胞数(24.8±3.70)明显少于对照组(47.6±4.28,q=10.68,P<0.01)及Ad-Lac Z组(49.6±4.39,q=11.61,P<0.01)。成瘤实验表明:Ad-s TRAIL对荷瘤鼠肿瘤的抑制率3 d为8.15%,6 d为11.55%,9 d为17.23%,12 d为20.05%,15 d为27.18%,18 d为34.27%,21 d为33.08%。免疫组化实验显示:Ad-s TRAIL组荷瘤鼠肿瘤组织中TRAIL表达水平明显高于Control组和Ad-Lac Z组。TUNEL实验显示:Ad-s TRAIL组荷瘤鼠肿瘤细胞凋亡水平明显高于Control组和Ad-Lac Z组。结论通过重组分泌型TRAIL腺病毒载体Ad-s TRAIL处理PC-3细胞荷瘤鼠,可以抑制裸鼠体内肿瘤细胞的增殖,促进前列腺癌细胞的凋亡。 Objective To investigate the suppression effect of secreting-trail adenovirus on the prostatecancer PC-3 cells in the tumor bearing mice. Methods Apoptosis of PC-3 cells was measured by DAPI staining in vitro. Invasion of PC-3 cells was measured by transwell chamber assay. The tumor bearing mice were prepared andused to test the inhibition rates in different groups. The protein expression of TRAIL in different groups tumorbearing mice was determined by immunohistochemistry. The variation of cell apoptosis in different groups of tumorbearing mice was detected by TUNEL assay. Results DAPI staining showed that the apoptosis level in Ad-sTRAILgroup was significantly higher than that in the control group and that in the Ad-Lac Z group,respectively. Thenumber of PC-3 cells invading the inferior chamber in the Ad-sTRAIL group(24.8 ± 3.70)was significantlydecreased compared with that in the control group(47.6 ± 4.28,q = 10.68,P〈0.01)and that in the Ad-Lac Z group(49.6 ± 4.39,q = 11.61,P〈0.01). Growth inhibition assays in vivo showed the inhibition rate of Ad-sTRAIL was3 d 8.15%,6 d 11.55%,9 d 17.23%,12 d 20.05%,15 d 27.18%,18 d 34.27%,and 21 d 33.08%,respective-ly. Immunohistochemistry results showed that the expression level of TRAIL in tumors of Ad-sTRAIL group tumor-bearing mice was significantly higher than that in the control group and that in the Ad-Lac Z group. TUNEL assayshowed that the apoptosis level of tumor bearing mice tumor cells in the Ad-sTRAIL group was significantly higherthan that in the control group and that in the Ad-Lac Z group. Conclusion The secreting-trail adenoviral vectorcould inhibit the growth of tumor bearing mice tumor cells,furthermore it could induce the apoptosis of PC-3 cellsin the tumor bearing mice.
作者 高磊 潘铁军 谢鸣 蒋渊 喻希 李想 GAO Lei, PAN Tiejun, XIE Ming, JIANG Yuan, YU Xi, LI Xiang.(Department of Urology, Wuhan General Hospital of People's Liberation Army of China, Wuhan 430070, Chin)
出处 《实用医学杂志》 CAS 北大核心 2018年第12期1951-1954,1958,共5页 The Journal of Practical Medicine
基金 国家自然科学基金资助项目(编号:81502210) 湖北省自然科学基金资助项目(编号:2015CFC863)
关键词 前列腺癌 荷瘤鼠 细胞凋亡 分泌型腺病毒载体 prostate cancer tumor bearing mice cell apoptosis secreting-trail adenoviral vector
  • 相关文献

参考文献2

二级参考文献11

  • 1Kim A, Kim M J, Yang Y, et al. Suppression of NF-κB activity by NDRG2 expression attenuates the invasive potential of highly malignant tumor cells [ J]. Carcinogenesis, 2009,30 (6) : 927-936.
  • 2Leed C, Kang Y K, Kim W H, et al. Functional and clinical evidence for NDRG2 as a candidate suppressor of liver cancer metastasis [ J ]. Cancer Res, 2008,68 ( 11 ) : 4210-4220.
  • 3Ma J, Jin H, Wang H, et al. Expression of NDRG2 in clear cell renal cell carcinoma [J]. Biol Pharm Bull,2008,31 (7):1316- 1320.
  • 4Lorentzen A, Vogel L K, Lewinsky R H, et al. Expression of NDRG2 is down-regulated in high-risk adenomas and colorectal carcinoma [J]. BMC Cancer,2007,12(7): 192.
  • 5Deng Y, Yao L, Chau L, et al. N-Myc downstream-regulated gene 2 (NDRG2) inhibits glioblastoma cell proliferation [J]. Int J Cancer, 2003,106 (3) : 342-347.
  • 6赫杰,赵平,陈万青.2011中国肿瘤登记年报[M].北京:军事医学科学出版社,2012:2-5,26 -37,74 -75.
  • 7Segi M. Cancer mortality for selected sites in 24 countries(1950-57 ) [ M ]. Japan : Department of Public Health,Tohoku Univer-sity of Medicine, 1960.
  • 8FerlayJ, Shin HR, Bray F, et al. Estimates of worldwide burdenof cancer in 2008 : GLOBOCAN 2008 [ J]. Int J Cancer, 2010,127(12) : 2893 -2917.
  • 9Jemal A, Bray F, Center MM, et al. Global cancer statistics[J]. CA Cancer J Clin’2011,61(2) :69 -90.
  • 10Siegel R, Naishadham D, Jemal A. Cancer statistics, 2012 [ J].CA Cancer J Clin,2012,62( 1) :10 - 29.

共引文献770

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部